Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The genetics of thrombosis in cancer].

Medicina clinica - 1 Jan 2015

Soria José Manuel, López Sonia

Abstract excerpt

Venous thromboembolism (VTE) is a multifactorial and complex disease in which the interaction of genetic factors (estimated at 60%) and environmental factors (e.g., the use of oral contraceptives, pregnancy, immobility and cancer) determine the risk of thrombosis for each individual. In particular, the association between thrombosis and cancer is well established. Approximately 20% of patients with cancer develop...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Clinical Decision-Making
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Neoplasms

Share to Risk Assessment

Share to Risk Factors

Share to Venous Thromboembolism

Source

Identifiers

PMID: 25771089
DOI: 10.1016/S0025-7753(15)30015-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The genetics of thrombosis in cancer].PMID 25771089Read ↗

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.Semantic proximity Read ↗

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients.Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort studySemantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.Semantic proximity Read ↗

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Impact of the mutation profile on thrombotic risk in cancer patients.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.Semantic proximity Read ↗

Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.